On November 7, 2025, a noteworthy study validating the Dozee device for contactless monitoring of vital signs was announced. The investigation focuses on the device’s capabilities in tracking heart rate, respiration, and movement with telemetry monitoring. This update should catch the attention of clinical, regulatory, and quality professionals evaluating advancements in non-invasive medical devices.
In this article:
- What changed?
- Study details
- Expected impact
- Frequently Asked Questions
- Conclusion
- Disclaimer
- Full announcement details
What changed?
Dozee, a contactless monitoring device developed by Turtle Shell Technologies Pvt. Ltd., is undergoing validation for its use in clinical settings to monitor heart, respiratory rates, and movement. This marks a significant step toward integrating novel technology into routine healthcare. ClinicalTrials.gov notes that the trial also involves oversight by Eastside Research Associates, emphasizing collaboration in research and development. The study is actively recruiting participants, aiming for broader evaluation of its technological reliability and healthcare applications.
Study details
What is telemetry monitoring?
Telemetry monitoring refers to the remote capture and transmission of data, which in this case includes heart and respiratory rates and physical activity metrics. Dozee utilizes contactless technology, removing traditional sensors or wearable devices. This innovation can streamline patient experiences without cumbersome equipment.
Who sponsors the study?
The study is sponsored by Turtle Shell Technologies Pvt. Ltd., the developers of the Dozee device, alongside Eastside Research Associates. Their collaboration underscores the initiative’s intention to clinically validate the performance of a new methodology for patient monitoring.
Expected impact
Why does contactless monitoring matter?
Contactless monitoring reduces the need for intrusive devices, addressing concerns of patient comfort and compliance. It has potential applications in home settings, hospitals, and remote healthcare, particularly where traditional monitoring methods are impractical.
Will this affect regulatory approval?
The validation study aims to generate data aligned with regulatory requirements in markets such as the US and Europe. Regulatory authorities will likely examine parameters such as safety, efficacy, and user experience for approval pathways.
Frequently Asked Questions
- What is Dozee?
Dozee is a contactless device designed for tracking heart rate, respiratory functions, and movement. - What is the study’s recruitment status?
The study is actively recruiting participants as per ClinicalTrials.gov. - Who is conducting the study?
Turtle Shell Technologies Pvt. Ltd. and Eastside Research Associates are leading the validation process.
Conclusion
The validation of Dozee represents a pivotal milestone in medical device technology, paving the way for integration into clinical and home care systems. Stakeholders should monitor further developments to understand its regulatory pathway and potential impact on patient care and industry practices.
Disclaimer
This article is intended for informational purposes and should not be construed as legal advice or formal regulatory guidance. Always refer to official documents and authorities for compliance matters.
Full announcement details
For full information about the announcement, see the link below.
https://clinicaltrials.gov/study/NCT07223931?term=medical+device